Over 111.7 mn unutilized Covid vaccine doses available with states, UTs

As part of the nationwide vaccination drive, the Centre has been supporting the states and UTs by providing them Covid-19 vaccines free of cost

Covid vaccine, covid-19
Covid vaccine
ANI
2 min read Last Updated : Feb 19 2022 | 10:50 AM IST

The Centre on Saturday said that more than 111.7 crore unutilized COVID-19 vaccine doses are still available with the states and Union Territories.

According to the Ministry of Health and Family Welfare, "More than 1.72 billion (1,720,492,970) vaccine doses have been provided to states/UTs so far through Central government (free of cost channel) and direct state procurement categories."

"More than 111.7 million (111,710,731) unutilized COVID-19 vaccine doses are still available with the states/UTs to be administered to the eligible people," it added.

The nationwide COVID-19 vaccination started on January 16, 2021. The new phase of universalization of COVID-19 vaccination commenced on June 21, 2021.

The vaccination drive has been ramped up through the availability of additional vaccines, advanced visibility of vaccine availability to states and UTs for enabling better planning by them and streamlining the vaccine supply chain.

As part of the nationwide vaccination drive, the Centre has been supporting the states and UTs by providing them COVID-19 vaccines free of cost.

In the new phase of the universalization of the COVID-19 vaccination drive, the Centre will procure and supply (free of cost) 75 per cent of the vaccines being produced by the manufacturers in the country to states and UTs.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronCoronavirus VaccineVaccineCoronavirus Tests

First Published: Feb 19 2022 | 10:44 AM IST

Next Story